Peri operative CA19-9 levels can predict stage and survival in patients resected for pancreatic adenocarcinoma

被引：0
|
作者：
Ferrone, CR
Thayer, SP
Finkelstein, DM
Muzikansky, A
Warshaw, AL
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2006年 / 13卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：38 / 39
页数：2
相关论文
共 50 条
  • [21] Postradiotherapy CA19-9 Kinetics Correlate With Outcomes in Patients With Pancreatic Adenocarcinoma
    Shultz, David B.
    Chan, Cato
    Shaffer, Jenny L.
    Kunz, Pamela L.
    Koong, Albert C.
    Chang, Daniel T.
    [J]. PANCREAS, 2014, 43 (05) : 777 - 783
  • [22] Prognostic value of CA19-9 in patients with pancreatic adenocarcinoma after chemoradiotherapy
    Nampei, Y.
    Toyomasu, Y.
    Ochiai, S.
    Mase, T.
    Watanabe, Y.
    Kawamura, T.
    Takada, A.
    Yamashita, Y.
    Li, N.
    Sakuma, H.
    Nomoto, Y.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S568 - S569
  • [23] Prognostic value of serum CEA and CA19-9 levels in pancreatic ductal adenocarcinoma
    Ermiah, Eramah
    Eddfair, Mona
    Abdulrahman, Othman
    Elfagieh, Mohamed
    Jebriel, Abdalla
    Al-Sharif, Mona
    Assidi, Mourad
    Buhmeida, Abdelbaset
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2022, 17 (02)
  • [24] Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma
    Xu, Hua-Xiang
    Liu, Liang
    Xiang, Jin-Feng
    Wang, Wen-Quan
    Qi, Zi-Hao
    Wu, Chun-Tao
    Liu, Chen
    Long, Jiang
    Xu, Jin
    Ni, Quan-Xing
    Yu, Xian-Jun
    [J]. SURGERY, 2017, 161 (02) : 373 - 384
  • [25] Prognostic Impact of CA19-9 Level at Diagnosis in Resected Stage I-III Pancreatic Adenocarcinoma: a US Population Study
    Mirkin, K.
    Hollenbeak, C.
    Wong, J.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 : 14 - 15
  • [26] A decrease in preoperative to postoperative CA19-9 level is a significant predictor of survival in patients with pancreatic adenocarcinoma.
    Ferrone, CR
    Thayer, SP
    Finkelstein, DM
    Muzikansky, A
    Mino-Kenudson, M
    Lauwers, G
    Warshaw, AL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 316S - 316S
  • [27] CA19-9 Levels in Saliva and Urine of Patients with Ductal Adenocarcinoma of the Pancreas Correlates with Serum CA19-9 Levels - A Prospective Preliminary Study
    Ben-Ishay, Offir
    Haim, Shirley Or
    Kaplan, Marielle
    Kluger, Yoram
    [J]. JOURNAL OF THE PANCREAS, 2016, 17 (01): : 66 - 69
  • [28] Prognostic Impact of Perioperative CA19-9 Levels in Patients with Resected Perihilar Cholangiocarcinoma
    Lee, Jong Woo
    Lee, Jae Hoon
    Park, Yejong
    Kwon, Jaewoo
    Lee, Woohyung
    Song, Ki Byung
    Hwang, Dae Wook
    Kim, Song Cheol
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (07)
  • [29] Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma
    Newhook, Timothy E.
    Vreeland, Timothy J.
    Griffin, James F.
    Tidwell, Rebecca S.
    Prakash, Laura R.
    Koay, Eugene J.
    Ludmir, Ethan B.
    Smaglo, Brandon G.
    Pant, Shubham
    Overman, Michael
    Wolff, Robert A.
    Ikoma, Naruhiko
    Maxwell, Jessica
    Kim, Michael P.
    Lee, Jeffrey E.
    Katz, Matthew H. G.
    Tzeng, Ching-Wei D.
    [J]. ANNALS OF SURGERY, 2023, 277 (03) : 484 - 490
  • [30] CA19-9 serum levels predict micrometastases in patients with gastric cancer
    Jagric, Tomaz
    Potrc, Stojan
    Mis, Katarina
    Plankl, Mojca
    Mars, Tomaz
    [J]. RADIOLOGY AND ONCOLOGY, 2016, 50 (02) : 204 - 211
12345